e.g. mhealth
Search Results (1 to 10 of 10 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 4 JMIR Research Protocols
- 2 JMIR Formative Research
- 1 JMIR Dermatology
- 1 JMIR Neurotechnology
- 1 JMIR mHealth and uHealth
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Parkinson disease (PD) is a neurodegenerative chronic disease, affecting around 145,000 people in the United Kingdom in 2018, equivalent to approximately 1 adult in every 350 [1]. The currently accepted monitoring of PD symptoms in clinical practice and trials is based on interviews and validated clinical scales and questionnaires [2].
JMIR Form Res 2025;9:e63704
Download Citation: END BibTex RIS
Affecting more than 8.5 million people worldwide in 2019, Parkinson disease (PD) is the second most common neurodegenerative disease [1]. PD is diagnosed using criteria from the UK Parkinson’s Disease Society Brain Bank [2] and is defined by the cardinal symptoms of tremor, bradykinesia, rigidity, and postural instability, along with other motor and nonmotor symptoms [3].
JMIR Res Protoc 2025;14:e58612
Download Citation: END BibTex RIS
Parkinson disease (PD) is a complex and progressive neurological condition with no current cure. It represents the second most common neurodegenerative disorder worldwide [1], with a 30% rise in prevalence and incidence between 2018 and 2030 [2,3]. Clinicians in PD care often have limited data due to infrequent patient contact, constraining their ability to fully inform treatment decisions [4]. The diversity of symptoms experienced by people with PD means that care management is complex.
JMIR Res Protoc 2024;13:e58845
Download Citation: END BibTex RIS
Individuals with Parkinson disease (PD) can improve their overall mobility and participation in daily activities as they engage in frequent exercise [1-6]. Further, exercise may provide a neuroprotective effect for these individuals, thereby limiting the progression of the disease [7]. As in other patient populations, individuals with PD demonstrate the greatest benefit from an exercise program that is designed to meet their specific needs [8,9].
JMIR Form Res 2024;8:e54599
Download Citation: END BibTex RIS
Based on the most globally prevalent and costly neurological disorders [11], studies investigating the use of NLP in Alzheimer disease (exclusive of Alzheimer disease–related disorders), Parkinson disease, stroke and transient ischemic attack, epilepsy, multiple sclerosis (MS), and migraine were included.
JMIR Neurotech 2024;3:e51822
Download Citation: END BibTex RIS
For the LBD group, participants will require a clinical diagnosis of established or prodromal Parkinson disease dementia, dementia with Lewy bodies, MCI due to Parkinson disease, or MCI due to LBD obtained from medical records. This may include participants with mixed dementia where LBD is considered a significant component to clinical presentation.
For the control group, participants will confirm that they have no known cognitive impairment or neurodegenerative condition.
JMIR Res Protoc 2024;13:e52652
Download Citation: END BibTex RIS
Seborrheic dermatitis (SD) is related to increased sebum production and an inflammatory response to cutaneous Malassezia, and it affects 18.6%-59% of persons with Parkinson disease (PD) [1,2]. The mechanism connecting these two pathologies is not entirely clear; however, increasing evidence suggests a direct role of Malassezia in the pathogenesis of PD [2].
JMIR Dermatol 2024;7:e49965
Download Citation: END BibTex RIS
Parkinson disease (PD) is the second most prevalent neurodegenerative disease worldwide, with around 10 million people with PD worldwide [1]. This number represents a 2.5-fold increase in prevalence over the past generation [2,3]. PD is a neurological disorder associated with motor and nonmotor features [4] affecting multiple aspects of movement, including planning, initiation, and execution [5]. Management of PD is very complex over the course of the disease due to its progressive nature [6].
JMIR Res Protoc 2023;12:e46581
Download Citation: END BibTex RIS
Post hoc analysis showed a significant difference between participants with Parkinson disease and those with lower-back pain for DTC of peak angular velocity for the head in both SDT and CDT conditions with participants with Parkinson disease, demonstrating a higher DTC (mean difference 33%, SD 9% and 32%, SD 10%, respectively; Figure 9).
More details regarding the pairwise comparisons for the investigated variables can be found in the Multimedia Appendix 1.
J Med Internet Res 2023;25:e41082
Download Citation: END BibTex RIS
Parkinson disease (PD) is a progressive neurodegenerative disease characterized by motor symptoms including tremors, rigidity, and bradykinesia, and nonmotor symptoms such as depression and cognitive impairment [1]. The physical activity level of patients with PD is approximately one-third of the general population because of their physical, cognitive, and emotional impairments.
JMIR Mhealth Uhealth 2021;9(8):e27662
Download Citation: END BibTex RIS